Enes Evren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Enes Evren has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
İsMail Özdemir
4 shared publications- Nevin Gürbüz
Catalysis Research and Application Center, İnönü University, Malatya, Turkiye
4 shared publications Nevin Gürbüz
3 shared publications- Ismail Ozdemir
İnönü Üniversitesi
2 shared publications - Abd El-Krim Sandeli
Pharmaceutical Sciences Research Center (CRSP) Constantine Algeria
1 shared publication Abdülmelik Aras
1 shared publication
Latest Publications
- Open Access
- 9 March 2026
- Published by International Journal of Secondary Metabolite in International Journal of Secondary Metabolite
- No. Advanced O
Assessment of cytotoxicity and antitumor activity of newly developed compounds in A549 lung cancer cells
Lung cancer is among the most common cancers in the world, and current treatments are inadequate due to the development of resistance and serious side effects. This situation brings new therapeutic strategies for cancer treatment. Among these, silver-based N-heterocyclic carbenes (Ag-NHCs) have emerged as promising candidates due to their unique chemical properties, such as strong metal-ligand bonding and modulation of biological reactivity. This study investigates the cytotoxic and antitumoral effects of newly synthesized Ag-NHC complexes on lung cancer (A549) cells. Ag-NHC complexes (X, Y, and Z) were synthesized using benzimidazolium salts and characterized by NMR spectroscopy. Cytotoxicity was evaluated on A549 and normal fibroblast (L929) cells using MTS assays. Apoptotic cell death and mitochondrial membrane potential were evaluated in A549 cells. Gene expression analysis for apoptosis-related markers was performed using RT-PCR. Ag-NHC complexes showed dose- and time-dependent antiproliferative effects in the A549 cell line. Annexin V/PI analysis revealed significant apoptotic induction by complexes X, Y and Z; the highest apoptotic rates were observed in A549 cells treated with Y and Z. Complexes Y and Z significantly decreased mitochondrial membrane potential, indicating increased apoptosis via intrinsic pathways. RT-PCR revealed increased pro-apoptotic gene expression (Bax, BAD, caspase-3, -8, -9) and decreased anti-apoptotic Bcl-2 expression in treated A549 cells. Complexes Y and Z also upregulated extrinsic apoptotic markers (DR4 and DR5). The newly synthesized Ag-NHC complexes (X, Y, Z) exhibited significant antiproliferative and pro-apoptotic effects in A549 lung cancer cells, indicating their potential as new therapeutic agents with reduced toxicity compared to conventional chemotherapy.
- 9 March 2026
- Published by International Journal of Secondary Metabolite in International Journal of Secondary Metabolite
- No. Advanced O
Open AccessAssessment of cytotoxicity and antitumor activity of newly developed compounds in A549 lung cancer cells
Lung cancer is among the most common cancers in the world, and current treatments are inadequate due to the development of resistance and serious side effects. This situation brings new therapeutic strategies for cancer treatment. Among these, silver-based N-heterocyclic carbenes (Ag-NHCs) have emerged as promising candidates due to their unique chemical properties, such as strong metal-ligand bonding and modulation of biological reactivity. This study investigates the cytotoxic and antitumoral effects of newly synthesized Ag-NHC complexes on lung cancer (A549) cells. Ag-NHC complexes (X, Y, and Z) were synthesized using benzimidazolium salts and characterized by NMR spectroscopy. Cytotoxicity was evaluated on A549 and normal fibroblast (L929) cells using MTS assays. Apoptotic cell death and mitochondrial membrane potential were evaluated in A549 cells. Gene expression analysis for apoptosis-related markers was performed using RT-PCR. Ag-NHC complexes showed dose- and time-dependent antiproliferative effects in the A549 cell line. Annexin V/PI analysis revealed significant apoptotic induction by complexes X, Y and Z; the highest apoptotic rates were observed in A549 cells treated with Y and Z. Complexes Y and Z significantly decreased mitochondrial membrane potential, indicating increased apoptosis via intrinsic pathways. RT-PCR revealed increased pro-apoptotic gene expression (Bax, BAD, caspase-3, -8, -9) and decreased anti-apoptotic Bcl-2 expression in treated A549 cells. Complexes Y and Z also upregulated extrinsic apoptotic markers (DR4 and DR5). The newly synthesized Ag-NHC complexes (X, Y, Z) exhibited significant antiproliferative and pro-apoptotic effects in A549 lung cancer cells, indicating their potential as new therapeutic agents with reduced toxicity compared to conventional chemotherapy.
- 13 February 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1363
Palladium-PEPPSI complexes: A robust and versatile catalyst system for the C–H arylation of heteroarenes
- 13 February 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1363
Palladium-PEPPSI complexes: A robust and versatile catalyst system for the C–H arylation of heteroarenes
- Open Access
- 22 December 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (1) , 409-424
Synthesis, characterization, and anticancer potential of novel NHC ligands and their selenium complexes: a combined in vitro and in silico investigation
We report herein the efficient synthesis of new benzimidazolium salts (A1–A6) and their corresponding selenium-NHC complexes (B1–B6), along with the evaluation of their cytotoxicity profiles against two cancer cell lines (HCT116 and SH-SY5Y) and one normal cell line (BEAS-2B). The findings revealed that the benzimidazolium salts (A1–A6) exhibited significantly higher cytotoxicity toward all tested cell lines compared to their selenium derivatives (B1–B6). Among them, compounds A3, A4, and A5 showed the most potent cytotoxic effects, with IC50 values ranging from 3.09 to 26.12 µM, approximately ten times lower than that of cisplatin. However, these compounds also exhibited relatively low IC50 values in normal BEAS-2B cells, although still higher than those observed in the cancer cell lines, indicating a preferential cytotoxicity toward cancer cells. Structure–activity relationship analysis revealed that the benzimidazolium core acts as the pharmacophore of these compounds, while substitution on the aromatic ring—particularly with bulky groups—enhances cytotoxicity. Conversely, incorporation of the selenium atom was found to markedly reduce or even eliminate cytotoxicity up to concentrations of 800 µM. Further in silico studies were conducted to gain a deeper understanding of the molecular structures and chemical reactivity of these compounds. In addition, molecular docking studies against PARP-1 and tubulin highlighted the strong inhibitory potential of the most active compounds (A3, A4, and A5) toward both targets, suggesting their potential involvement in the observed cytotoxic effects. Overall, these investigations propose benzimidazolium salts A3, A4, and A5 as promising anticancer agents and highlight the selenium derivatives as non-toxic selenium-based NHC complexes. Further studies should be undertaken to optimize the biological activity of these compounds and to enhance their selectivity toward cancer cells.
- 22 December 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (1) , 409-424
Open AccessSynthesis, characterization, and anticancer potential of novel NHC ligands and their selenium complexes: a combined in vitro and in silico investigation
We report herein the efficient synthesis of new benzimidazolium salts (A1–A6) and their corresponding selenium-NHC complexes (B1–B6), along with the evaluation of their cytotoxicity profiles against two cancer cell lines (HCT116 and SH-SY5Y) and one normal cell line (BEAS-2B). The findings revealed that the benzimidazolium salts (A1–A6) exhibited significantly higher cytotoxicity toward all tested cell lines compared to their selenium derivatives (B1–B6). Among them, compounds A3, A4, and A5 showed the most potent cytotoxic effects, with IC50 values ranging from 3.09 to 26.12 µM, approximately ten times lower than that of cisplatin. However, these compounds also exhibited relatively low IC50 values in normal BEAS-2B cells, although still higher than those observed in the cancer cell lines, indicating a preferential cytotoxicity toward cancer cells. Structure–activity relationship analysis revealed that the benzimidazolium core acts as the pharmacophore of these compounds, while substitution on the aromatic ring—particularly with bulky groups—enhances cytotoxicity. Conversely, incorporation of the selenium atom was found to markedly reduce or even eliminate cytotoxicity up to concentrations of 800 µM. Further in silico studies were conducted to gain a deeper understanding of the molecular structures and chemical reactivity of these compounds. In addition, molecular docking studies against PARP-1 and tubulin highlighted the strong inhibitory potential of the most active compounds (A3, A4, and A5) toward both targets, suggesting their potential involvement in the observed cytotoxic effects. Overall, these investigations propose benzimidazolium salts A3, A4, and A5 as promising anticancer agents and highlight the selenium derivatives as non-toxic selenium-based NHC complexes. Further studies should be undertaken to optimize the biological activity of these compounds and to enhance their selectivity toward cancer cells.
- 19 September 2023
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1295
Plausible PEPPSI catalysts for direct C-H functionalization of furans and pyrroles
- 19 September 2023
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1295
Plausible PEPPSI catalysts for direct C-H functionalization of furans and pyrroles
- 1 May 2021
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1231
Synthesis and in silico studies of Novel Ru(II) complexes of Schiff base derivatives of 3-[(4-amino-5-thioxo-1,2,4-triazole-3-yl)methyl]-2(3H)-benzoxazolone compounds as potent Glutathione S-transferase and Cholinesterases Inhibitor
- 1 May 2021
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1231
Synthesis and in silico studies of Novel Ru(II) complexes of Schiff base derivatives of 3-[(4-amino-5-thioxo-1,2,4-triazole-3-yl)methyl]-2(3H)-benzoxazolone compounds as potent Glutathione S-transferase and Cholinesterases Inhibitor
- 31 December 2020
- Published by International Journal of Pure and Applied Sciences in International Journal of Pure and Applied Sciences
- Vol. 6 (2) , 200-207
A Computational Study on Some Pyridine-Substituted-Bis-1,2,4-Triazole Derivatives and Investigation of Their Catalytic Activities
In this work were specified catalytic activity of pyridine-substituted-bis-1,2,4-triazole (PBTT) derivative ligands 5,5′-(pyridine-2,5-diyl)bis(4-ethyl-4H-1,2,4-triazole-3-thiol) (L1) and 5,5′-(pyridine-2,5-diyl)bis(4-phenyl-4H-1,2,4-triazole-3-thiol) (L2) in biaryl synthesis in situ-reaction condition. Catalytic activities are determined in terms of conversion percentages to derivatives of biaryl of aryl bromides by GC-MS. The highest catalytic effect for L1 ligand was measured as 61% with 4-bromobenzaldehyde. Apart from catalytic activity studies, some structural properties of related ligands were discussed by computational methods. As a result, the ground state geometries, frontier molecular orbitals (FMOs) and also the maps of molecular electrostatic potential (MEP) of L1 and L2 ligands were obtained using DFT/B3LYP/6-31+G(d) calculations. Additionally, the global reactivity descriptors were reached using the FMOs calculations.
- 31 December 2020
- Published by International Journal of Pure and Applied Sciences in International Journal of Pure and Applied Sciences
- Vol. 6 (2) , 200-207
A Computational Study on Some Pyridine-Substituted-Bis-1,2,4-Triazole Derivatives and Investigation of Their Catalytic Activities
In this work were specified catalytic activity of pyridine-substituted-bis-1,2,4-triazole (PBTT) derivative ligands 5,5′-(pyridine-2,5-diyl)bis(4-ethyl-4H-1,2,4-triazole-3-thiol) (L1) and 5,5′-(pyridine-2,5-diyl)bis(4-phenyl-4H-1,2,4-triazole-3-thiol) (L2) in biaryl synthesis in situ-reaction condition. Catalytic activities are determined in terms of conversion percentages to derivatives of biaryl of aryl bromides by GC-MS. The highest catalytic effect for L1 ligand was measured as 61% with 4-bromobenzaldehyde. Apart from catalytic activity studies, some structural properties of related ligands were discussed by computational methods. As a result, the ground state geometries, frontier molecular orbitals (FMOs) and also the maps of molecular electrostatic potential (MEP) of L1 and L2 ligands were obtained using DFT/B3LYP/6-31+G(d) calculations. Additionally, the global reactivity descriptors were reached using the FMOs calculations.
- 1 September 2020
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1216
Azo-azomethine based palladium(II) complexes as catalysts for the Suzuki-Miyaura cross-coupling reaction
- 1 September 2020
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1216
Azo-azomethine based palladium(II) complexes as catalysts for the Suzuki-Miyaura cross-coupling reaction
- 1 June 2020
- Published by Elsevier in Inorganica Chimica Acta
- Vol. 506
Synthesis, characterization and antitumor properties of novel silver(I) and gold(I) N-heterocyclic carbene complexes
- 1 June 2020
- Published by Elsevier in Inorganica Chimica Acta
- Vol. 506
Synthesis, characterization and antitumor properties of novel silver(I) and gold(I) N-heterocyclic carbene complexes